Month: January 2022

Categories
Pharmaceutical

COVID-19 Saliva-Based Detection Kits Market

As per Fact.MR – market research and competitive intelligence provider, the global COVID-19 saliva-based detection kits market was valued at US$ 1.4 Bn in 2020, with demand expected to decline at a CAGR of -2.8% over the forecast period (2021-2031).

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=6902

COVID-19 is a severe and infectious disease, with diagnosis at the initial stage playing a significant role in stopping the further increase of cases. At present, the old method of sampling, i.e., nasopharyngeal swab is majorly used for testing. However, the emerging technique of saliva-based testing is a promising alternative for COVID-19 diagnosis.

When patients need to get urgent care for more critical flu-like symptoms, physicians need to perform diagnostic tests as soon as possible. To meet this requirement, test kits should be available at cheaper costs, easy to handle, rapid, and equipment-free. This creates an opportunity for market players to come up with innovative devices to fulfil the requirements of patients and physicians in the future.

Due to rising approvals of COVID-19 test kits that are convenient and simple to use, manufacturers are aiming to introduce new products in the market and get them approved.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=6902

  • For Instance, in July 2021, Nalagenetics and Nusantics obtained regulatory approval to launch PCR test kits to detect COVID-19 from saliva samples. These kits will function as alternatives to nasal and throat swab tests.

Leading players are focusing on advancements in in-vitro diagnostic procedures with rapid testing. These advancements are expected to gain popularity and generate high revenue in the market.

  • For instance, in April 2021, Therma Bright Inc. announced that it had received CE approval from an EU-competent authority of Belgium for its AcuVid™ COVID-19 rapid antigen saliva test.

Key Takeaways from Market Study

  • By product, PCR-based kits hold around 73.5% value share of the global market in 2021.
  • Based on technology, RT-qPCR is leading with 49.2% market share in 2021.
  • Based on application, COVID-19 diagnosis is leading with 63.1% market share in 2021.
  • By end user, diagnostic laboratories dominate the market with a value share of 26.8% in 2021, while on the other hand, academic and research institutes are expected to increase at a higher CAGR of 2.5%.
  • By country, the U.S. dominates the North America market with a value share of 91% in 2021.

Key Segments Covered in COVID-19 Saliva-based Detection Kits Industry Research

  • By Product

    • Rapid Test Kits
    • PCR-based Kits

  • By Technology

    • Direct Sample to PCR
    • RT-qPCR
    • Lateral Flow Assays

  • By Application

    • COVID-19 Research
    • COVID-19 Diagnostics

  • By End User

    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Academic and Research Institutes
    • Biopharma  Companies
    • Long Term Care Facilities
    • Home Care Settings
    • Others

Crucial insights in the COVID-19 Saliva-Based Detection Kits Market research:

  • Underlying macro- and microeconomic factors impacting the growth of the COVID-19 Saliva-Based Detection Kits Market Basic overview of the COVID-19 Saliva-Based Detection Kits Market including market definition, classification, and applications.
  • Scrutinization of each COVID-19 Saliva-Based Detection Kits Market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend of COVID-19 Saliva-Based Detection Kits Market across various industries.
  • Important regions and countries offering lucrative opportunities to COVID-19 Saliva-Based Detection Kits Market stakeholders.

Speak to the Experts – https://www.factmr.com/connectus/sample?flag=AE&rep_id=6902

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Increasing Research Supported by Progressing R&D and Diagnostic Technologies to Amplify Tumour-Induced Osteomalacia Market Demand: States Fact.MR

Tumour-induced osteomalacia or oncogenic osteomalacia is a rare paraneoplastic syndrome of bone which consist of osteomalacia or rickets induced by phosphaturic mesenchymal tumour (PMT). Tumour-induced osteomalacia diagnosed with an elevated level of blood fibroblast growth factor 23 (FGF23), phosphate and vitamin D-regulating hormone. According to Maastricht University Hospital research, paraneoplastic syndrome affects 8% of cancer patients.

Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5255

Tumour-Induced Osteomalacia Market Segmentation

The global tumour-induced osteomalacia market is segmented into treatment, diagnosis, end-user and regions.

By treatment, the global tumour-induced osteomalacia market is further segmented into:

  • Drugs
    • Burosumab-twza
    • Cinarcalcet
  • Supplements
    • Calcium (Cinarcalcet,
    • Vitamin D (Calcitriol or Alphacalcidio)
    • Phosphorus
  • Surgery

By diagnosis, the global tumour-induced osteomalacia market is further segmented into:

  • Laboratories
    • Elevated blood Fibroblast growth factor 23 (FGF-23)
    • Serum calcium, PTH, vitamin D
    • Hyperphosphaturia (Secondary effects of the FDF-23)
    • Hypophosphatemia (Secondary effects of the FDF-23)
  • Bone Scan
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT Scan)
  • Differential Diagnosis
    • Vitamin D metabolism and deficiency
    • Osteoporosis
    • Renal Osteodystrophy
    • Others

By end-user, the global tumour-induced osteomalacia market is further segmented into:

  • Hospitals
  • Clinics

Tumour Induced Osteomalacia Market: Drivers and Restraints

The global tumour-induced osteomalacia market is driven by the escalating R&D, close collaboration of research institutes, recent successful clinical trials, drug approvals and pipeline drugs. The governments have dedicated funds for orphan drug research and rare diseases which also pushes the tumour-induced osteomalacia market growth. Research bodies and manufacturers are working with the deliberated focus to develop novel diagnostics and therapeutics for tumour-induced osteomalacia. Drugs such as recently FDA approved tumour-induced osteomalacia drug, Burosumab and fast track designated by FDA, BGJ398 is expected to drive the tumour-induced osteomalacia market growth prospects.

However, several restraints decelerate the tumour-induced osteomalacia such as the high expenses of research which eventually adds cost to the diagnostics and treatment. The treatment of tumour-induced osteomalacia possess challenges such as lack of awareness, the dearth of knowledge among clinical professionals and patients since the disease is rare and only 500 cases reports since the first case reported in 1947, therefore limited data in the literature, restricted patient and clinical data. Tumour-induced osteomalacia drugs require repeated dosage and adverse reactions. Although, the overall tumour-induced osteomalacia market is expected to grow lucratively with a gradual pace with the advancing research and dedicated databases for rare diseases and increasing understanding of the disease pathophysiology.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5255

Tumour Induced Osteomalacia Market: Key Players

The key players of global tumour-induced osteomalacia market include Kyowa Kirin Co., Ltd., Taizhou Hisound Pharmaceutical Co., Ltd., Zhejiang Garden Biochemical High-tech Co., Ltd., Kingdomway Nutrition, Inc., Amgen Inc., Forgo Pharmaceuticals Pvt. Ltd., Abbott, Solvay, GE Healthcare, Siemens and others.

Tumour Induced Osteomalacia Market: Regional Outlook

The global tumour-induced osteomalacia market is expected to grow gradually further with the advancing research, drug approvals and clinical trials. By treatment, the segment of surgery is anticipated to lead the tumour-induced osteomalacia treatment, since surgeries are considered safer than the drugs for their adverse reactions, repeated dosages of drugs, effective tumour destructions, controlling the serum phosphate level and pain relief.

By diagnosis, the bone scans are anticipated to dominate the segment with their sophisticated technology and high expenditure. By end-user, hospitals are expected to rule the segment with their highly advanced infrastructure and expenditure, diagnostics, patient care for tumour-induced osteomalacia and highly experienced medical professionals.

North America is anticipated to lead the global tumour-induced osteomalacia market with its highly advanced research infrastructure, diagnostics and treatment, close collaborations between research institutes and hospitals, dedicated funds and programs for rare disease research and orphan drugs development. Europe is anticipated holds the second-largest tumour-induced osteomalacia market with its sophisticated R&D and diagnostics technology and escalated investments into the research.

Asia-Pacific tumour-induced osteomalacia market is anticipated to grow eventually with the progressing research infrastructure and investments of nations such as China and India. Latin America tumour-induced osteomalacia market is expected to have a very gradual growth with its awareness programs. The Middle East and Africa tumour-induced osteomalacia market are anticipated to be stagnant due to the underdeveloped research and healthcare infrastructure and lack of awareness.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=5255

The Report Covers Exhaustive Analysis On:

  • Tumour-Induced Osteomalacia Market Drivers, Segments and Restraints.
  • Tumour-Induced Osteomalacia Market Survey and Dynamics
  • Tumour-Induced Osteomalacia Market Size & Demand
  • Tumour-Induced Osteomalacia Key Trends/Issues/Challenges
  • Tumour-Induced Osteomalacia Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Zellweger Spectrum Disorders Market Is Anticipated To Grow With The Escalating Research And Progressing Clinical Understanding Of The Disease

Zellweger spectrum disorders are the spectrum of rare multisystem and autosomal inherited genetic disease which affects most of the organs. Zellweger spectrum disorders are incurred by the defected PEX gene and are covered under peroxisomal biogenesis disorders. According to Orphanet, Zellweger spectrum disorders affects one in every 50,000 individuals in North America and every 500,000 in Japan. These diseases were once categorized as separate entities, however, these different variants are termed as one disease according to their shared biochemical basis.

Request For Sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=5254

The global Zellweger spectrum disorders market is segmented into therapy, diagnosis, end-user and regions.

By therapy, the global Zellweger spectrum disorders market is further segmented into:

  • Pediatricians
  • Neurologists
  • Surgeons
  • Audiologists (treat hearing problems)
  • Ophthalmologists (treat vision problems)
  • Orthopedists (treat skeletal abnormalities)

By diagnosis, the global Zellweger spectrum disorders market is further segmented into:

  • Blood and Urine test
  • Ultrasound
  • Genetic tests

By end-user, the global Zellweger spectrum disorders market is further segmented into:

  • Hospitals
  • Clinics

Request For Customization  –  https://www.factmr.com/connectus/sample?flag=RCrep_id=5254

Zellweger Spectrum Disorders Market: Key Players

The key players of Zellweger spectrum disorders market include PerkinElmers Inc., Trivitron Healthcare, Chromsystems Instruments & Chemicals GmbH., CENTOGENE N.V., LifeCell International Pvt. Ltd., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Seimens and others.

Zellweger Spectrum Disorders Market: Regional Outlook

The global Zellweger spectrum disorders market is anticipated to grow with the escalating research and therapy advancements. By therapy, the segment is divided into pediatricians, neurologists, Surgeons, Audiologists for hearing issues, ophthalmologists for vision issues and Orthopedists for skeletal abnormalities.

By diagnosis, the Zellweger spectrum disorders market is divided into blood and urine test, ultrasound and genetic test. Initial diagnosis includes blood and urine test to check the elevated level of very-long-chain fatty acids (VLCFA). By end-user, hospitals dominates the segment with the advanced diagnosis and treatment of the Zellweger spectrum disorders, with close collaboration with research institutes.

North America is anticipated to dominate the global Zellweger spectrum disorders market with its advanced research and healthcare infrastructure, mandatory newborn screening test and sophisticated diagnostics. Europe is anticipated to hold the second-largest Zellweger spectrum disorders market with the initiatives of newborn screening tests, dedicated research programs and collaborations. Asia-Pacific Zellweger spectrum disorders market is expected to grow in future with the research progress and new findings and advancing diagnostics.

Latin America Zellweger spectrum disorders market is expected to grow with a slow pace since its research is at its infancy, challenges in research and diagnostics. The Middle East& Africa Zellweger spectrum disorders market is expected to remain stagnant due to the underdeveloped research and healthcare infrastructure and lack of awareness.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Growing Geriatric Population Along with Awareness Drives and Campaigns will Upsurge Ptosis Treatment Market Growth: States Fact.MR

Ptosis is a condition of drooping or falling upper eyelid. It is also called referred as blepharoptosis. If condition is severe and ptosis treatment is not conducted, it may lead to development of condition called amblyopia or astigmatism which is a refractive eye condition in which the eye is unable to focus appropriate light on the retina. The causes for the development of ptosis is dysfunction of the Müller’s muscle that lifts the eye. It is more common in the elderly as eyelid muscles tend to deteriorate with age.

Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5253

Ptosis Treatment Market: Segmentation

The ptosis treatment market can be segmented based on treatment, service provider and region.

Based on the treatment, the global ptosis treatment market is segmented as:

  • Mechanical Treatment
    • Ptosis Crutches
    • Special Scleral Contact Lenses
    • Ptosis Taping
  • Non-mechanical Treatment
    • Botulinum Injection (BOTOX)
    • Ulthera
    • Oxymetazoline Hydrochloride Ophthalmic
  • Others

Based on the service provider, the global ptosis treatment market is segmented as:

  • Hospitals
  • Eye Specialty Clinics
  • Cosmetic Surgery Clinics
  • Medical Spas
  • Others

Ptosis Treatment Market: Drivers and Restraints

Growing geriatric population globally which is most prone to suffer from this condition is a major driver which is expected to propel the growth of the global market of ptosis treatment. Awareness drives and campaigns, like the one planned by Osmotica Pharmaceutical to make people aware about the ptosis and ptosis treatment is further expected to boost the growth of the global market of ptosis treatment.

Technological advancements and non-surgical options which are preferred by the patients will also contribute to the growth of the global ptosis treatment market. The restraints for the global market of ptosis treatment could be unawareness about the ptosis and ptosis treatment in general and in underdeveloped or developing nations in particular. Inability to diagnose the condition will add to the challenges that can hamper the growth of the global market of ptosis treatment.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5253

Ptosis Treatment Market: Key Players

The key players operating in the global market of ptosis treatment are Vertical Pharmaceuticals (Osmotica Pharmaceuticals), Ipsen, Merz Pharma, Allergan, Bausch and Lomb among others.

Ptosis Treatment Market: Regional Outlook

North America can be expected to be a dominant market in the global ptosis treatment market because of the existence of robust healthcare research infrastructure and accessibility of advanced healthcare facilities together with awareness among the people about the availability of non-surgical ptosis treatment options. The Asia Pacific might be expected to hold a significant growth rate of ptosis treatment market owing to the high incidence rates of ptosis in the countries like China.

Europe may also be estimated to hold a robust revenue share in the global ptosis treatment market owing to the growing awareness and growing geriatric population especially in the Western European nations. Middle East and Africa may be expected to be the least lucrative markets in the global ptosis treatment market owing to resource and infrastructure limitations coupled with limited awareness about ptosis and ptosis treatment options.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=5253

The Report Covers Exhaustive Analysis On:

  • Ptosis Treatment Market Drivers, Segments and Restraints.
  • Ptosis Treatment Market Survey and Dynamics
  • Ptosis Treatment Market Size & Demand
  • Ptosis Treatment Key Trends/Issues/Challenges
  • Ptosis Treatment Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Increasing Patient Population from Liver Diseases in Developing Countries to Fuel Sales of Byler Disease Market: States Fact.MR

Byler Disease is also known as progressive familial intrahepatic cholestasis. Byler disease is an inherited diseases which is caused by a faulty gene. Sometimes, in children with byler diseases, the liver cells cannot release bile juice, fluid which helps the body to digest food. So due to which this cause many symptoms such as itching, jaundice, delayed puberty and impaired growth. Number of novel, manufactures has shown improvement in clinical trials such as Phenobarbital or Rifampin and many other for the treatment of byler disease.

Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5252

Byler Disease Market Segmentation

The global byler disease Market is segmented on the basis of Treatment and End User.

On the basis of Treatment, Byler Disease Market Segmentation into:

  • Medical Treatment
    • Phenobarbital or Rifampin
    • Others
  • Surgical Treatment
    • Laser surgery
    • Cryosurgery
    • Laparoscopic surgery
    • Others

On the basis of End User, Byler Disease Market Segmentation into:

  • Research Centers
  • Hospitals
  • Clinics
  • Others

Furthermore, increasing patient population from liver diseases in developing countries will directly increase the demand for various treatment methods and will boost the growth of the byler disease market. Some of the major key players competing in the global Merck & Co. Inc., Sanofi AG, Novartis AG, Bayer AG, GlaxoSmithKline plc, AstraZeneca PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gilead Science Inc., and Johnson & Johnson Private Limited and others.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5252

Regional Byler Disease market

The global byler disease is majorly dominated by the surgical treatment among treatment segment. Among the surgical treatment, laser surgery becoming more popular as they can be used to treat or repair different part of the body to find out the location of the disease which is then followed by cryosurgery, a procedure which is used to destroy the unwanted tissues with the help of nitrogen liquid.

Hospitals will generate largest revenue share in byler disease market as the hospitals use advanced technology medical devices for patient care and also instant care will be available with use of surgical treatment to treat chronic disease patients.

COVID-19 which, originated in the city of Wuhan, Mainland China, has spread aggressively to evolve into a global pandemic involving more than 170 countries. This pandemic has affected lives across the economic, social and political sphere. According to a study, the heart patients are more sensitive to COVID 19 infection.

According to a study by Chinese Center for Disease Control and Prevention (CCDC), the deaths of COVID 19 positive patients having heart related medical history was 10.5%, aids in cardiac cure using cardiac defibrillator, which is the primary focus of doctors and physicians alike at the moment, as this infection has no available cure. A breakthrough at this moment can hamper the stock prices of cardiac defibrillator manufacturers including byler disease Market.

North America is projected to emerge as prominent market in the global byler disease market due to increasing prevalence of chronic disease along with updating technology for rare diseases treatment methods. Europe is expected to hold prominent share in the global byler disease market throughout the study period due to encouraging government policies for research & development and healthcare professionals by various Asian and European countries.Asia Pacific is the fastest growing market owing to more number of developing nations such as India, china are encouraging the growth of the healthcare domain.

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current Byler Disease market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in Byler Disease market.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=5252

The Report Covers Exhaustive Analysis On:

  • Byler Disease Market Drivers, Segments and Restraints.
  • Byler Disease Market Survey and Dynamics
  • Byler Disease Market Size & Demand
  • Byler Disease Key Trends/Issues/Challenges
  • Byler Disease Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Growing Number Of Millennial Pet Owners Will Provide Push To Global Canine Parvovirus Market Sales, Fact.MR Study

Canine parvovirus is a contagious virus affecting dog population. The affected dogs suffer from gastrointestinal infections due parvovirus. It is a highly infectious diseases caused by either direct or indirect contact with infected fecal matter of other infected dogs.

The major symptoms include vomiting, bloody diarrhea, lethargy together with fever. The gestation period for the symptoms to occur range from three to seven days. Dehydration caused due to vomiting and diarrhea can make cases critical as this destroys the electrolyte balance of the body and makes the immune system weak.

Request Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=5196

Canine Parvovirus Market: Drivers and Restraints
The major driver for the global canine parvovirus market would the growing pet owners worldwide which is evident from the fact that the number of pet owners has more than tripled in the USA from 1970s. The increasing income disposability of people coupled with their willingness to invest in pet care can be yet another driver for the global canine parvovirus market. The shift in the way pets are cared for and growing number of millennial pet owners can also provide push to the global canine parvovirus market. The major barrier in the development of the global canine parvovirus market could be the general unawareness among the pet owners about the canine parvovirus in the developing countries.

Canine Parvovirus Market: Segmentation The global canine parvovirus market is segmented based on the drug class, route of administration, distribution channel and region.

By drug class, the global canine parvovirus treatment market is segmented as:

  • Antibiotics
  • Antiemetics
  • Intravenous (IV) Fluids
  • Others 

By route of administration, the global canine parvovirus treatment market is segmented as:

  • Intravenous
  • Oral 

By distribution channel type, the global canine parvovirus market is segmented as:

  • Hospital Pharmacies
  • Online Pet Drugs Stores
  • Veterinary Drugs Stores 

Request for Customized Report here –  https://www.factmr.com/connectus/sample?flag=RC&rep_id=5196

Canine Parvovirus Market: Key Players
The major players operating in the global canine parvovirus market are Merck Animal Health, Zoetis United States, Amber Naturalz, Merial (Sanofi), MSD Animal Health, Durvet, Elanco among others.

Canine Parvovirus Market: Region-wise

North America is expected to constitute the major share in the global canine parvovirus treatment market since it is estimated that the households in the USA spend around 50 billion USD annually on pet care. Europe can be the next attractive market since it has a pet dog population of around 75 million. Asia can be expected as the emerging market in the global canine parvovirus treatment market since there are many countries like China, India and Japan with growing pet dog population. Middle East along with Africa can be estimated to register sluggish growth in the global canine parvovirus treatment market due to low income disposability and adoption in the region.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

North America Is Expected To Dominate the Global Ambulatory Heart Monitor Market 2021-2031

Ambulatory heart monitor is a cardiac activity monitoring and recording device which uses non invasive electrocardiogram (EKG) to record heart rhythm for 24-72 hours. Such cardiac activity monitoring by ambulatory heart monitor is crucial for cardiovascular diseases (CVD).

The global ambulatory heart monitor market is anticipated to grow with the rising cardiovascular diseases, expanding geriatric population, high demand for ambulatory heart monitors for its utility, efficacy and cost-effectiveness and technological enhancements.

 Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5195

The global ambulatory heart monitor market is segmented into type, end-users and regions.

By type, the global ambulatory heart monitor market is further segmented into:

  • Mobile Cardiac Telemetry
  • Holter Monitor
  • Event Monitors
  • Others

By end-users, the global ambulatory heart monitor market is further segmented into:

  • Hospitals
  • Ambulatory Care Centers
  • Other

Key questions answered in Ambulatory Heart Monitor Market Survey Report:

  1. What is the current scenario and key trends in Ambulatory Heart Monitor Market?
  2. What are the key strategies companies are adopting to increase their consumer base?
  3. What are the key categories within the Ambulatory Heart Monitor segments and their future potential?
  4. What are the major Ambulatory Heart Monitor Market drivers and their expected impact during the short, medium, and long terms?
  5. What is the Ambulatory Heart Monitor Market size and what are the opportunities for the key players?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5195

Key Players

The key players of global ambulatory heart monitor market include

  • GE Healthcare
  • Medtronic
  • iRhythm
  • BioTelemetry
  • Abbott
  • Boston Scientific
  • BIOTRONIK

Essential Takeaways from the this Market Report

  • Comparison of prominent players operating in the market.
  • Recent developments and key strategies adopted by key players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain.
  • Evaluation of current Absorbent Dressing market size, forecast and technological advancements within the industry.
  • Current Insights influencing the scenario and key trends in Absorbent Dressing market.

Enquire Before Buying Here –  https://www.factmr.com/connectus/sample?flag=EB&rep_id=5195

The Report Covers Exhaustive Analysis On:

  • Ambulatory Heart Monitor Market Drivers, Segments and Restraints.
  • Ambulatory Heart Monitor Market Survey and Dynamics
  • Ambulatory Heart Monitor Market Size & Demand
  • Ambulatory Heart Monitor Key Trends/Issues/Challenges
  • Ambulatory Heart Monitor Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Booming Demand from Emerging Economies to Upsurge Absorbent Dressing Market Growth Globally

Absorbent dressing is not applicable for dry wounds, thus confining its applications to wet wounds only. Although the overall global absorbent dressing market is anticipated to grow with its escalating demand for burns, accidents and other wound-care, also the rising awareness, availability, affordability and efficacy will elevate the market further. Key players are developing novel absorbent dressing with improved efficacy, healing capacity and safety.

Request for Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=5194  

The global absorbent dressing market is segmented into type, application, end-users and regions. 

By type, the global absorbent dressing market is further segmented into:

  • Traditional Wound Dressings
  • Advanced Wound Dressings 

By application, the global absorbent dressing market is further segmented into:

  • Surgical Wounds
  • Traumatic Wounds 

By end-user, the global absorbent dressing market is further segmented into:

  • Inpatient Facilities
  • Outpatient Facilities

The global absorbent dressing market is poised to lucratively with its high demand wound-care, its efficacy, safety and healing leading to high acceptance. By type, advanced wound dressings lead the absorbent dressing type due to advanced wound dressing foams with anti-microbial and effective healing such as alginates, hydrocolloids, foams, films, collagen, hydrogels and others. By applications, surgical wounds dominate the absorbent dressing application with major attribution by the surgeries of chronic diseases’ surgeries. By end-users, inpatient facilities rule the absorbent dressing market end-users due to the hospitals wherein massive numbers of surgeries are performed, and require admission and stay of patients.

North America holds the largest global absorbent dressing market due to the largest pool of chronic wounds, geriatric populations, increasing healthcare expenditure, key players of absorbing dressing. Europe holds the second largest global absorbent dressing market driven by its highly advanced wound care technology and wide range absorbent dressing products. Asia-pacific absorbent dressing market is growing at the fastest rate with attributing factors such as the giant patient pool of diabetic foot, ulcers, geriatric population, burns and road accidents, in China and India. Latin America absorbent dressing market is growing sound with the high prevalence of chronic wounds, trauma, and other injuries. Improving healthcare infrastructure and rising awareness are also contributing to the regional absorbent dressing market growth. MEA &Africa absorbent dressing market is growing with the rising demand of absorbent dressing for geriatric patients and chronic wound-care including burns, accidents and others.

The key players of global absorbent dressing market include 3M, ConvaTec, Medtronic, Lohmann & Rauscher (L&R), Hollister, Johnson & Johnson, Alliqua BioMedical, Inc., Smith & Nephew, Integra Lifesciences, B. Braun, Coloplast, DeRoyal Inc., Mölnlycke Health Care and DermaRite.

After reading the report, readers get insight into:

  • Major drivers and restraining factors, opportunities and challenges, and the competitive landscape
  • New, promising avenues in key regions
  • New revenue streams for all players in emerging markets
  • Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions
  • Demand and uptake patterns in key industries of the
  • New research and development projects in new technologies in key regional markets
  • Changing revenue share and size of key product segments during the forecast period 2018 to 2028
  • Technologies and business models with disruptive potential

Request for Customization here- https://www.factmr.com/connectus/sample?flag=RC&rep_id=5194

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.

Read More Trending Reports of Fact.MR : https://www.biospace.com/article/drug-discovery-services-market-players-are-shifting-towards-r-and-d-outsourcing/

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Prepackaged Medical Kits and Trays Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

Cables and Leads for Medical Equipment Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

Coatings for Medical Devices Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

Rapid Technological and Diagnostics Advancements to Propel PDA Closure Devices Market Demand

PDA closure devices are the medical devices to cure congenital heart condition called patent ductus arteriosus (PDA). Patent ductus arteriosus is the opening in between two major blood vessels leading to the heart called ductus arteriosus. Ductus arteriosus is a normal element of infant’s circulatory before birth which naturally closes after birth, however, if it remains open even after the birth, the opening is called patent ductus arteriosus.

 Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5193

PDA Closure Devices Market: Segmentation

The global PDA closure devices market is segmented into product type, end-user, and region.

By the product type, the global PDA closure devices market is further segmented into:

  • Stainless Steel
  • Titanium
  • Others

By the end-users, the global PDA closure devices market is further segmented into:

  • Hospitals
  • Clinics
  • Others

PDA Closure Devices Market: Key Players

The key players of global PDA closure devices market include Abbott, Lifetech, Boston Scientific, Lepu Medical Technology (Beijing) Co., Ltd., Coherex Medical Inc., MicroPort, Occlutech and others.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5193

PDA Closure Devices Market: Regional Outlook

Europe holds the dominance in the global PDA closure devices market with the massive application of PDA closure devices, advanced medical technology, robust R&D, highly-developed healthcare infrastructure and key players. North America holds the second-largest global PDA closure devices market with its advanced healthcare infrastructure and medical technologies.

Asia-Pacific PDA closure devices market is the fastest-growing market, fuelled by the massive geriatric population pool, progressing medical technology and research, and the government awareness programmes and its research and healthcare funding.

Latin America PDA closure devices market is growing moderately with its gradually improving healthcare infrastructure and technological improvement, along with growing awareness of congenital heart diseases of the high prevalence of congenital heart defects. The Middle East & Africa PDA closure devices market is stagnant due to the under-developed healthcare in infrastructure and lack of awareness.

Enquire Before Buying Here –  https://www.factmr.com/connectus/sample?flag=EB&rep_id=5193

The Report Covers Exhaustive Analysis On:

  • PDA Closure Devices Market Drivers, Segments and Restraints.
  • PDA Closure Devices Market Survey and Dynamics
  • PDA Closure Devices Market Size & Demand
  • PDA Closure Devices Key Trends/Issues/Challenges
  • PDA Closure Devices Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Non-Hormonal Steroid Modulators Market Anticipated to Register Significant CAGR Due to Rising Healthcare Infrastructure: States Fact.MR

Non-hormonal steroid modulators are the biological ligands or compound that binds to the receptor as agonist or antagonist to alter the biological reaction associated with the receptors. Beside their steroidal nature, non-hormonal steroid modulators don’t bind hormone receptors.

World Health Organization (WHO), one in every 3000 inpidual is affected with Muscular dystrophy, over 9.6 million lives have been claimed by cancer and prevalence of arthritis 0.3% and 1%, with higher prevalence in females.

To Get In-depth Insights Request for Sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5192

Non-Hormonal Steroid Modulators Market: Segmentation

The global non-hormonal steroid modulators are segmented into by modulator type, indication and region.

By modulator type, the global non-hormonal steroid modulators are further segmented into:

  • RU49953
  • Non-Hormonal Steroid NF-κB Modulator

By indication, the global non-hormonal steroid modulators are further segmented into:

  • Arthritis
  • Muscular Dystrophy
  • Cancer Drug-Resistance (Drug Efflux)

Non-Hormonal Steroid Modulators Market: Key Players

The key player of the non-hormonal steroid modulators market is

  • ReveraGen
  • Biopharma Inc.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5192

Non-Hormonal Steroid Modulators Market: Regional Outlook

Europe dominates the global non-hormonal steroid modulators market with its leading research studies and clinical trials, the European market is pushed by the high prevalence of arthritis in this region, and special attention of European Commission towards muscular dystrophy therapies. North America holds the second-largest non-hormonal steroid modulators market with its active R&D activities, key players and non-hormonal steroid modulators patent claimed for muscular dystrophy and arthritis.

Asia-Pacific non-hormonal steroid modulators are expected to bloom in future, with the massive burden of arthritis, escalating research and improving healthcare, along with the support of government funding. Latin America non-hormonal steroid modulator market is expected to grow moderately with improving research and healthcare. The Middle East & Africa non-hormonal steroid modulators market is expected to remain stagnant due to the under-developed medical healthcare and R&D infrastructure.

Latin America is expected to grow at a moderate rate with the gradual elevation of the research and technology. The Middle East & Africa is expected to have a stagnant growth due to the under-developed research infrastructure.

Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=5192

The Report Covers Exhaustive Analysis On:

  • Non-Hormonal Steroid Modulators Market Drivers, Segments and Restraints.
  • Non-Hormonal Steroid Modulators Market Survey and Dynamics
  • Non-Hormonal Steroid Modulators Market Size & Demand
  • Non-Hormonal Steroid Modulators Key Trends/Issues/Challenges
  • Non-Hormonal Steroid Modulators Sales, Competition & Companies involved

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com